Floatz logo

Secretin

Intraductal Papillary Mucinous Neoplasm

Fundacion Clinic per a la Recerca Biomédicaprotein_peptidePhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Intraductal Papillary Mucinous Neoplasm cohort.

Asset / SponsorPhaseRating
Capecitabine
National Cancer Institute (NCI)
Phase 3BB
FLUOROURACILUM
National Cancer Institute (NCI)
Phase 3BB
Vitamin E Delta Tocotrienol
H. Lee Moffitt Cancer Center and Research Institute
Phase 2CCC
Sulindac
Duke University
Phase 2CCC
rg1068
Massachusetts General Hospital
Phase 1CC
Ferumoxytol
OHSU Knight Cancer Institute
N/AD
ly4337713
Eli Lilly and Company
Phase 1NR

Same molecule, other indications

Secretin is also rated in:

Gene MutationDormant
B
Indicative ·
60 / 100
View asset →
Lynch syndromeDormant
B
Indicative ·
60 / 100
View asset →
malignant pancreatic neoplasmDormant
CCC
Indicative ·
54 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →